Develops and commercializes drug-coated balloons (DCBs) and drug-eluting stents for treating coronary and peripheral artery disease. Products feature a SAFEPAX paclitaxel coating matrix with very low wash-off and are supported by ongoing clinical research for interventional cardiologists and vascular specialists.